Compare BL & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BL | NEOG |
|---|---|---|
| Founded | 2001 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2016 | 1995 |
| Metric | BL | NEOG |
|---|---|---|
| Price | $28.00 | $9.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $56.62 | $10.67 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-05-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.13 | 0.02 |
| Revenue | $177,031,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $12.62 | N/A |
| Revenue Next Year | $10.90 | N/A |
| P/E Ratio | ★ $218.00 | $479.00 |
| Revenue Growth | ★ 43.78 | N/A |
| 52 Week Low | $24.70 | $4.56 |
| 52 Week High | $59.57 | $11.43 |
| Indicator | BL | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 49.12 |
| Support Level | $25.46 | $8.86 |
| Resistance Level | $31.23 | $9.50 |
| Average True Range (ATR) | 1.49 | 0.36 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 60.24 | 35.14 |
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.